Featured Firms
Presented by BigVoodoo
The Federal Trade Commission is on track to approve Johnson & Johnson $24.7 billion acquisition of Guidant Corp. shortly after the first week of September. The FTC is expected to order J&J to license a technique used for implanting stents in arteries. Since streamlining the merger review process is a priority for the FTC, Chairwoman Deborah Majoras has said the agency will be more willing to accept licensing deals rather than divestitures as a solution to concentration concerns.
August 22, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
Duane Morris seeks an associate with 3-4 years of experience to join its Employee Benefits and Executive Compensation Group in its Philadelp...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS